孕早期子宫胎盘血管形态发育与胚胎及胎儿生长正相关:鹿特丹围孕期队列研究
本研究基于鹿特丹围孕期队列的214例持续妊娠亚队列,于孕7、9、11周获取三维能量多普勒容积并生成子宫胎盘血管骨架(uPVS),评估血管形态发育与胚胎生长、胎儿生长及出生体重百分位的关联。研究发现绝对血管形态发育与胚胎生长指标正相关,而血管分支密度与孕晚期估计胎儿体重及出生体重百分位负相关,关联主要在自然受孕中观察到。
要点
- uPVS作为新型影像标志物,其绝对血管形态发育与孕早期胚胎生长正相关。
- 血管分支密度与孕晚期估计胎儿体重及出生体重百分位呈负相关。
- 上述关联在自然受孕妊娠中特异性地观察到。
核心结论
- 孕早期子宫胎盘血管形态发育与胚胎生长、胎儿生长及出生体重百分位正相关。
研究设计与样本
- 研究嵌套于前瞻性观察性鹿特丹围孕期队列(Predict研究),为VIRTUAL胎盘研究亚队列,纳入214例持续妊娠。
- 受试者在孕10周前于荷兰一家三级转诊医院纳入,纳入时间为2017年1月至2018年3月。
- 于孕7、9、11周获取包含胚胎和胎盘的三维能量多普勒容积,经虚拟现实分割和骨架化算法生成uPVS并测量子宫胎盘血管体积(uPVV)。
- 采用线性混合模型估计纵向测量轨迹,并采用校正混杂因素的线性回归分析评估uPVS轨迹与产前生长的关联。
- 分析按受孕方式(自然受孕/体外受精-卵胞浆内单精子注射受孕)、胎儿性别(男/女)及胎盘相关并发症发生(是/否)分层。
主要发现
- 绝对血管形态发育增加(以uPVS特征的正向随机截距估计)与头臀长增加相关:端点β=0.017,95%CI[0.009;0.025];分叉点β=0.012,95%CI[0.006;0.018];交叉点β=0.017,95%CI[0.008;0.025];血管点β=0.01,95%CI[0.002;0.008];总血管长度β=0.007,95%CI[0.003;0.010],所有P值≤0.01。
- 绝对血管形态发育增加与胚胎体积及Carnegie分期也呈类似正相关,所有P值≤0.01。
- 血管分支密度与孕晚期估计胎儿体重负相关:端点与uPVV比值β=-94.972,95%CI[-185.245;-3.698];分叉点与uPVV比值β=-192.601,95%CI[-360.532;-24.670],所有P值<0.05。
- 血管分支密度与出生体重百分位负相关:端点与uPVV比值β=-20.727,95%CI[-32.771;-8.683];分叉点与uPVV比值β=-51.097,95%CI[-72.257;-29.937];交叉点与uPVV比值β=-48.604,95%CI[-74.246;-22.961],所有P值<0.05。
- 分层后,上述关联仅在自然受孕妊娠中观察到。
临床怎么用
- 作者认为,研究结果支持子宫胎盘血管发育的形态学变异参与胚胎和胎儿生长发育相关血管机制的假说。
- 作者认为,应用uPVS可能有助于理解胎盘相关并发症的病理生理机制。
- 作者提出,未来研究应关注uPVS作为影像标志物用于胎儿生长受限早期检测的临床适用性。
局限性
- 尽管这项前瞻性观察性研究清楚展示了孕早期子宫胎盘血管形态发育与产前生长的关联,但在得出确切的因果关系结论之前仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is morphologic development of the first-trimester utero-placental vasculature associated with embryonic growth and development, fetal growth, and birth weight percentiles? SUMMARY ANSWER: Using the utero-placental vascular skeleton (uPVS) as a new imaging marker, this study reveals morphologic development of the first-trimester utero-placental vasculature is positively associated with embryonic growth and development, fetal growth, and birth weight percentiles. WHAT IS KNOWN ALREADY: First-trimester development of the utero-placental vasculature is associated with placental function, which subsequently impacts embryonic and fetal ability to reach their full growth potential. The attribution of morphologic variations in the utero-placental vascular development, including the vascular structure and branching density, on prenatal growth remains unknown. STUDY DESIGN, SIZE, DURATION: This study was conducted in the VIRTUAL Placental study, a subcohort of 214 ongoing pregnancies, embedded in the prospective observational Rotterdam Periconception Cohort (Predict study). Women were included before 10 weeks gestational age (GA) at a tertiary referral hospital in The Netherlands between January 2017 and March 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: We obtained three-dimensional power Doppler volumes of the gestational sac including the embryo and the placenta at 7, 9, and 11 weeks of gestation. Virtual Reality-based segmentation and a recently developed skeletonization algorithm were applied to the power Doppler volumes to generate the uPVS and to measure utero-placental vascular volume (uPVV). Absolute vascular morphology was quantified by assigning a morphologic characteristic to each voxel in the uPVS (i.e. end-, bifurcation-crossing-, or vessel point). Additionally, total vascular length (mm) was calculated. The ratios of the uPVS characteristics to the uPVV were calculated to determine the density of vascular branching. Embryonic growth was estimated by crown-rump length and embryonic volume. Embryonic development was estimated by Carnegie stages. Fetal growth was measured by estimated fetal weight in the second and third trimester and birth weight percentiles. Linear mixed models were used to estimate trajectories of longitudinal measurements. Linear regression analysis with adjustments for confounders was used to evaluate associations between trajectories of the uPVS and prenatal growth. Groups were stratified for conception method (natural/IVF-ICSI conceptions), fetal sex (male/female), and the occurrence of placenta-related complications (yes/no). MAIN RESULTS AND THE ROLE OF CHANCE: Increased absolute vascular morphologic development, estimated by positive random intercepts of the uPVS characteristics, is associated with increased embryonic growth, reflected by crown-rump length (endpoints β = 0.017, 95% CI [0.009; 0.025], bifurcation points β = 0.012, 95% CI [0.006; 0.018], crossing points β = 0.017, 95% CI [0.008; 0.025], vessel points β = 0.01, 95% CI [0.002; 0.008], and total vascular length β = 0.007, 95% CI [0.003; 0.010], and similarly with embryonic volume and Carnegie stage, all P-values ≤ 0.01. Density of vascular branching was negatively associated with estimated fetal weight in the third trimester (endpoints: uPVV β = -94.972, 95% CI [-185.245; -3.698], bifurcation points: uPVV β = -192.601 95% CI [-360.532; -24.670]) and birth weight percentiles (endpoints: uPVV β = -20.727, 95% CI [-32.771; -8.683], bifurcation points: uPVV β -51.097 95% CI [-72.257; -29.937], and crossing points: uPVV β = -48.604 95% CI [-74.246; -22.961])), all P-values < 0.05. After stratification, the associations were observed in natural conceptions specifically. LIMITATION, REASONS FOR CAUTION: Although the results of this prospective observational study clearly demonstrate associations between first-trimester utero-placental vascular morphologic development and prenatal growth, further research is required before we can draw firm conclusions about a causal relationship. WIDER IMPLICATIONS OF THE FINDINGS: Our findings support the hypothesis that morphologic variations in utero-placental vascular development play a role in the vascular mechanisms involved in embryonic and fetal growth and development. Application of the uPVS could benefit our understanding of the pathophysiology underlying placenta-related complications. Future research should focus on the clinical applicability of the uPVS as an imaging marker for the early detection of fetal growth restriction. STUDY FUNDING/COMPETING INTEREST(S): This research was funded by the Department of Obstetrics and Gynecology of the Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. There are no conflicts of interest. TRIAL REGISTRATION NUMBER: Registered at the Dutch Trial Register (NTR6854).
引用
- De Vos ES, Mulders AGMGJ, Koning AHJ, et al. Morphologic development of the first-trimester utero-placental vasculature is positively associated with embryonic and fetal growth: the Rotterdam Periconception Cohort. Hum Reprod. 2024. PMID: 38503486. doi:10.1093/humrep/deae056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。